TB and Sarcoidosis Granuloma - Trial NCT06396910
Access comprehensive clinical trial information for NCT06396910 through Pure Global AI's free database. This phase not specified trial is sponsored by Karolinska Institutet and is currently Completed. The study focuses on Tuberculosis,Sarcoidosis. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Karolinska Institutet
Timeline & Enrollment
N/A
Sep 01, 2021
Jul 01, 2023
Primary Outcome
Spatial transcriptome of lung lesions of sarcoidosis and tuberculosis patients
Summary
Tuberculosis (TB) and sarcoidosis are both granulomatous diseases. Here we compared the
 immunological micro-environments of granulomas from TB and sarcoidosis patients using in situ
 sequencing (ISS) transcriptomic analysis and multiplexed immunolabelling of tissue sections.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06396910
Non-Device Trial